News | April 25, 2023
Tricog raises US$ 8.5 million in series B2 funding
The funding will be used to expand the product line for remote patient monitoring and to scale the business across Asia and Africa
The funding will be used to expand the product line for remote patient monitoring and to scale the business across Asia and Africa
Bridging the gap between histopathology and molecular pathology
A special technique of jet injection is used to make vaccination almost painless and totally needleless.
Biocon Biologics Limited will have access to 100 million doses of vaccines annually together with the distribution rights to Serum's Vaccine portfolio
CEQUA is the first dry eye treatment available in India that is delivered with nanomicellar (NCELL) technology
Malaria is a life-threatening parasitic infection that is spread by the bites of mosquitoes carrying the Plasmodium parasite
Fully equipped labs with 75-member team set-up and made operational in <100 days
With a focus on optimizing patient experience with next-generation oral dosage forms, the US facility complements the cutting-edge research activities of Roquette’s existing pharma innovation centers in France and Singapore
SÜDPACK is setting standards in terms of both performance and sustainability
Marksans will continue to supply existing products until the end of 2023 to Teva's affiliates, ensuring high-quality standards
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
